DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity

Hypertension

Volumn 41, Issue 3 I, 2003, Pages 422-430

  Lopes, Heno F ^a,c   Martin, Kelley L ^b   Nashar, Khaled ^a   Morrow, Jason D ^d   Goodfriend, Theodore L ^e   Egan, Brent M ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Antioxidants; F2 isoprostanes; Fatty acids; Insulin resistance; Obesity; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; HEPARIN; INTRALIPID; ISOPROSTANE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; FEMALE; HEMODYNAMICS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEAN BODY WEIGHT; MALE; MEASUREMENT; NUTRITION; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; VOLUNTEER;

ACUTE DISEASE; ADULT; ANTIOXIDANTS; BLOOD PRESSURE; CROSS-OVER STUDIES; ELECTROLYTES; F2-ISOPROSTANES; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN RESISTANCE; LIPIDS; MALE; OBESITY; OXIDATIVE STRESS;

EID: 0037340057     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000053450.19998.11     Document Type: Article

References (41)

1. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens. 1989;2:125S-132S.
2. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
3. Lee KU. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract. 2001;54(suppl 2):S29-S33.
4. Facchini FS, Hua NW, Reaven GM, Stoohs RA. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radic Biol Med. 2000;29:1302-1306.
5. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-267.
6. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405-412.
7. 2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin. E Eur J Pharmacol. 1999;377:89-92.
8. Ceriello A. Oxidative stress and glycemic regulation. Metabolism. 2000;49:27-29.
9. Egan BM, Greene EL, Goodfriend TL. Insulin resistance and cardiovascular disease. Am J Hypertens. 2001;14:116S-125S.
10. El Midaoui A, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by α-lipoic acid. Hypertension. 2002;39:303-307.
11. Stojiljkovic MP, Zhang D, Lopes HF, Lee CG, Goodfriend TL, Egan BM. Hemodynamic effects of lipids in humans. Am J Physiol. 2001;280:R1674-R1679.
12. 2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens. 2002;20:1-7.
13. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension. 2000;36:142-146.
14. Laursen JB RS, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:557-559.
15. Duffy SJ GN, Holbrook M, Huang A, Frei B, Keaney JF Jr, Vita JA. Treatment of hypertension with ascorbic acid. Lancet. 1999;354:2048-2049.
16. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-1124.
17. Harris JA, Benedict FG. A Biometric Study of Basal Metabolism in Man. Washington DC: Carnegie Institute of Washington (Carnegie Institute of Washington publication No. 279), 1919.
18. Trabulsi J, Schoeller DA. Evaluation of dietary assessment instruments against doubly labeled water, a biomarker of habitual energy intake. Am J Physiol. 281:E891-E899.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
20. Besch W, Woltanski KP, Keilacker H, Diaz-Alonso JM, Schulz B, Amendt P, Kohnert KD, Ziegler M. Measurement of insulin in human sera using a new RIA kit, 1: insulin determination in the absence of insulin antibodies-conventional assay and micro modification. Exp Clin Endocrinol. 1987;90:264-270.
21. De Bruin TW, Brouwer CB, Gimpel JA, Erkelens DW. Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am J Physiol. 1991;260:E492-E498.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
23. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239:70-76.
24. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990;87:9383-9387.
25. 2-isoprostane) metabolites in human urine and plasma. J Biol Chem. 1993;268:4161-4169.
26. Haas JA, Krier JD, Bolterman RJ, Juncos LA, Romero JC. Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension. 1999;34:983-986.
27. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;85:753-766.
28. Therond P, Bonnefont-Rousselot D, Davit-Spraul A, Conti M, Legrand A. Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care. 2000;3:373-384.
29. Tse WY, Maxwell SR, Thomason H, Blann A, Thorpe GH, Waite M, Holder R. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens. 1994;8:843-849.
30. Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension. 2001;37:261-267.
31. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 2001;38:606-611.
32. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987;16:235-251.
33. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity: European Group for the Study of Insulin Resistance (EGIR). J Clin Invest. 1997;100:1166-1173.
34. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 1978;298:1-6.
35. Nakano Y, Oshima T, Sasaki S, Higashi Y, Ozono R, Takenaka S, Miura F, Hirao H, Matsuura H, Chayama K, Kambe M. Calorie restriction reduced blood pressure in obesity hypertensives by improvement of autonomic nerve activity and insulin sensitivity. J Cardiovasc Pharmacol. 2001;38(suppl 1):S69-S74.
36. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
37. Sacks FM, Brown LE, Appel L, Borhani NO, Evans D, Whelton P. Combinations of potassium, calcium, and magnesium supplements in hypertension. Hypertension. 1995;26:950-956.
38. Gu D, He J, Wu X, Duan X, Whelton PK. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J Hypertens. 2001;19:1325-1331.
39. Ishimitsu T, Tobian L, Sugimoto K, Everson T. High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens. 1996;18:659-673.
40. Maulik D, Zanelli S, Numagami Y, Ohnishi ST, Mishra OP, Delivoria-Papadopoulos M. Oxygen free radical generation during in-utero hypoxia in the fetal guinea pig brain: the effects of maturity and of magnesium sulfate administration. Brain Res. 1999;817:117-122.
41. Cohn JN. New approaches to screening for vascular and cardiac risk. Am J Hypertens. 2001;14:218S-220S.